Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.35 |
| ▸ | FAAH | O00519 | 2/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.34 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1269355 | 0.76 | MAPT (0.37) | KDM4EP2RX7ALDH1A1MAPTHPGD | |
| SCHEMBL30978073 | 0.76 | MAPT (0.37) | KDM4EP2RX7ALDH1A1MAPTHPGD | |
| SCHEMBL5475249 | 0.75 | KDM4E (0.53) | KDM4EP2RX7ALDH1A1MAPTHPGD | |
| Acrylic Acid SCHEMBL11105271 | 0.74 | ALDH1A1 (0.36) | KDM4EP2RX7ALDH1A1MAPTHPGD | |
| SCHEMBL28223258 | 0.71 | ALDH1A1 (0.45) | KDM4ECYP2C9ALDH1A1MAPTHPGD | |
| SCHEMBL3103198 | 0.70 | KDM4E (0.43) | KDM4EP2RX7ALDH1A1MAPTHPGD | |
| Hydrochloric Acid SCHEMBL2710119 | 0.70 | CYP2C9 (0.44) | KDM4ECYP2C9ALDH1A1MAPTHPGD | |
| SCHEMBL6853710 | 0.69 | KDM4E (0.42) | KDM4EP2RX7ALDH1A1MAPTHPGD | |
| SCHEMBL30855591 | 0.69 | — | — | |
| SCHEMBL2747082 | 0.69 | KDM4E (0.47) | KDM4EP2RX7ALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2739169-B1 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | MASSACHUSETTS INST TECHNOLOGY (US) | 2019-06-12 | — | — | EP | claimed |
| US-20140311507-A1 | Porous Catalytic Matrices for Elimination of Toxicants Found in Tobacco Combustion Products | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-10-23 | — | — | US | claimed |
| EP-2739169-A2 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | Massachusetts Institute Of Technology (US) | 2014-06-11 | — | — | EP | claimed |
| WO-2013019865-A2 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-02-07 | — | — | WO | claimed |
| US-12630567-B2 | High yield synthesis of metal-organic frameworks | ExxonMobil Technology and Engineering Company (US) | 2026-05-19 | — | — | US | disclosed |
| US-20250276300-A1 | REDUCTION OF MONOMERIC ISOCYANATES BY POROUS MATERIAL | BASF SE (DE) | 2025-09-04 | — | — | US | disclosed |
| EP-4291588-B1 | REDUCTION OF MONOMERIC ISOCYANATES BY POROUS MATERIAL | BASF SE (DE) | 2025-08-20 | — | — | EP | disclosed |
| CN-112352334-B | Cathode for lithium-sulfur battery and cathode for sodium-sulfur battery | 约翰霍普金斯大学 | 2025-03-25 | — | — | CN | disclosed |
| US-12227526-B2 | Metal-organic framework materials comprising a diimine scaffold and methods for production thereof | ExxonMobil Technology and Engineering Company (US) | 2025-02-18 | — | — | US | disclosed |
| EP-3947396-B1 | METAL-ORGANIC FRAMEWORK MATERIALS COMPRISING A DIIMINE SCAFFOLD AND METHODS FOR PRODUCTION THEREOF | EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) | 2024-12-11 | — | — | EP | disclosed |
| US-20240336636-A1 | METAL-ORGANIC FRAMEWORK | THE UNIVERSITY OF LIVERPOOL (GB) | 2024-10-10 | — | — | US | disclosed |
| US-12107210-B2 | Lithium-sulfur and sodium-sulfur battery cathodes | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-10-01 | — | — | US | disclosed |
| EP-1689670-A1 | METHOD FOR THE CONTROLLED STORAGE AND RELEASE OF GASES USING AN ELECTROCHEMICALLY PRODUCED CRYSTALLINE, POROUS, ORGANOMETALLIC SKELETON MATERIAL | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-16 | — | — | EP | disclosed |
| EP-1687462-A1 | METHOD FOR ELECTROCHEMICAL PRODUCTION OF A CRYSTALLINE POROUS METAL ORGANIC SKELETON MATERIAL | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-09 | — | — | EP | disclosed |
| WO-2006072573-A2 | ADSORPTIVE PRODUCTION OF XENON FROM KRYPTON/XENON GAS MIXTURES | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-13 | — | — | WO | disclosed |
| EP-1674555-A1 | Concentration of methane in methane containing gas mixtures by adsorption | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-28 | — | — | EP | disclosed |
| WO-2005049484-A1 | METHOD FOR THE CONTROLLED STORAGE AND RELEASE OF GASES USING AN ELECTROCHEMICALLY PRODUCED CRYSTALLINE, POROUS, ORGANOMETALLIC SKELETON MATERIAL | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-02 | — | — | WO | disclosed |
| WO-2005049892-A1 | METHOD FOR ELECTROCHEMICAL PRODUCTION OF A CRYSTALLINE POROUS METAL ORGANIC SKELETON MATERIAL | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-02 | — | — | WO | disclosed |
| EP-1471997-A1 | METHOD FOR STORING, ABSORBING AND EMITTING GASES USING NOVEL FRAMEWORK MATERIALS | BASF AKTIENGESELLSCHAFT (DE) | 2004-11-03 | — | — | EP | disclosed |
| WO-2003064030-A1 | METHOD FOR STORING, ABSORBING AND EMITTING GASES USING NOVEL FRAMEWORK MATERIALS | BASF AKTIENGESELLSCHAFT (DE) | 2003-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12227526-B2 | Metal-organic framework materials comprising a diimine scaffold and methods for production thereof | PICALM, ILK, CAD | KDM4E 3487/4885P2RX7 3130/4885CYP2C9 2777/4885 |
| US-12630567-B2 | High yield synthesis of metal-organic frameworks | ODC1, POF1B, DDC | KDM4E 1783/4885P2RX7 3609/4885CYP2C9 2941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.